{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T05:36:47Z","timestamp":1735969007020,"version":"3.32.0"},"reference-count":59,"publisher":"Georg Thieme Verlag KG","issue":"01","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thromb Haemost"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1055\/a-2495-1993","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T23:43:28Z","timestamp":1735947808000},"page":"085-091","source":"Crossref","is-referenced-by-count":0,"title":["Thrombosis and Haemostasis 2024 Editors' Choice Papers"],"prefix":"10.1055","volume":"125","author":[{"given":"Christian","family":"Weber","sequence":"additional","affiliation":[{"name":"Institute for Cardiovascular Prevention (IPEK), LMU Munich, Munich, Germany"},{"name":"German Centre for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany"},{"name":"Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, Maastricht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Rigby","sequence":"additional","affiliation":[{"name":"Institute for Cardiovascular Prevention (IPEK), LMU Munich, Munich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-1626","authenticated-orcid":false,"given":"Gregory Y. H.","family":"Lip","sequence":"additional","affiliation":[{"name":"Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart and Chest Hospital, Liverpool, United Kingdom"},{"name":"Department of Clinical Medicine, Aalborg University, Aalborg, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2025,1,3]]},"reference":[{"issue":"12","key":"ref1","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1055\/a-2434-9244","article-title":"The 2024 European Society of Cardiology guidelines for diagnosis and management of atrial fibrillation: a viewpoint from a practicing clinician's perspective","volume":"124","author":"T Potpara","year":"2024","journal-title":"Thromb Haemost"},{"issue":"01","key":"ref2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-0043-1772773","article-title":"Non-vitamin K antagonist oral anticoagulant, warfarin, and ABC pathway adherence on hierarchical outcomes: Win Ratio analysis of the COOL-AF registry","volume":"124","author":"S Treewaree","year":"2024","journal-title":"Thromb Haemost"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"100967","DOI":"10.1016\/j.lanepe.2024.100967","article-title":"Comparing CHA2DS2-VA and CHA2DS2-VASc scores for stroke risk stratification in patients with atrial fibrillation: a temporal trends analysis from the retrospective Finnish AntiCoagulation in Atrial Fibrillation (FinACAF) cohort","volume":"43","author":"K Teppo","year":"2024","journal-title":"Lancet Reg Health Eur"},{"issue":"20","key":"ref4","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/eurheartj\/ehae198","article-title":"Ischaemic stroke in women with atrial fibrillation: temporal trends and clinical implications","volume":"45","author":"K Teppo","year":"2024","journal-title":"Eur Heart J"},{"issue":"04","key":"ref5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1055\/s-0043-1776394","article-title":"Sex as a risk factor for atrial fibrillation-related stroke","volume":"124","author":"B Corica","year":"2024","journal-title":"Thromb Haemost"},{"issue":"10","key":"ref6","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1055\/a-2325-5923","article-title":"2024 Chinese Expert Consensus Guidelines on the diagnosis and treatment of atrial fibrillation in the elderly, endorsed by Geriatric Society of Chinese Medical Association (Cardiovascular Group) and Chinese Society of Geriatric Health Medicine (Cardiovascular Branch): executive summary","volume":"124","author":"Y Wang","year":"2024","journal-title":"Thromb Haemost"},{"issue":"08","key":"ref7","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1055\/s-0044-1782688","article-title":"Practical suggestions for an optimal management of vitamin K antagonists: Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA) position paper","volume":"124","author":"S Galliazzo","year":"2024","journal-title":"Thromb Haemost"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1055\/a-2332-6426","article-title":"Scottish Intercollegiate Guidelines Network guidance on dementia: the investigation of suspected dementia (SIGN 168) with focus on biomarkers\u2014executive summary","author":"G A Mackay","year":"2024","journal-title":"Thromb Haemost"},{"issue":"09","key":"ref10","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1055\/s-0044-1785511","article-title":"Pharmacokinetics of edoxaban 15\u2009mg in very elderly patients with nonvalvular atrial fibrillation: a subanalysis of the ELDERCARE-AF study","volume":"124","author":"T Yamashita","year":"2024","journal-title":"Thromb Haemost"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1055\/a-2365-8681","article-title":"Timing of off-label dosing of direct oral anticoagulants in three large health systems","author":"G C Herron","year":"2024","journal-title":"Thromb Haemost"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1055\/a-2441-8902","article-title":"Off-label dosing of direct oral anticoagulants: prescribing error or opportunity in treating patients with atrial fibrillation?","author":"D Poli","year":"2024","journal-title":"Thromb Haemost"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1055\/a-2379-7288","article-title":"The efficacy and safety of DOACs in inherited antithrombin deficiency: a cohort study from a tertiary referral center","author":"C Dix","year":"2024","journal-title":"Thromb Haemost"},{"issue":"08","key":"ref14","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1055\/a-2261-1811","article-title":"Algorithm for rapid exclusion of clinically relevant plasma levels of direct oral anticoagulants in patients using the DOAC Dipstick: an expert consensus paper","volume":"124","author":"J Harenberg","year":"2024","journal-title":"Thromb Haemost"},{"issue":"01","key":"ref15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1055\/s-0043-1778032","article-title":"Thrombosis and Haemostasis 2023 Editors' Choice Papers","volume":"124","author":"C Weber","year":"2024","journal-title":"Thromb Haemost"},{"issue":"03","key":"ref16","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1055\/s-0042-1760257","article-title":"Protocol for a systematic review and individual participant data meta-analysis of randomized trials of screening for atrial fibrillation to prevent stroke","volume":"123","author":"S Af","year":"2023","journal-title":"Thromb Haemost"},{"issue":"01","key":"ref17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/a-2127-0690","article-title":"The report of community-based and government-endorsed screening program of atrial fibrillation in Taiwan","volume":"124","author":"T F Chao","year":"2024","journal-title":"Thromb Haemost"},{"issue":"11","key":"ref18","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1055\/s-0043-1769612","article-title":"Mobile health-technology-integrated care for atrial fibrillation: a Win Ratio analysis from the mAFA-II randomized clinical trial","volume":"123","author":"G F Romiti","year":"2023","journal-title":"Thromb Haemost"},{"issue":"11","key":"ref19","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1055\/a-2299-4758","article-title":"Machine learning-based predictive models for patients with venous thromboembolism: a systematic review","volume":"124","author":"V Danilatou","year":"2024","journal-title":"Thromb Haemost"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1055\/a-2438-5671","article-title":"TARGET: a major European project aiming to advance the personalised management of atrial fibrillation-related stroke via the development of health virtual twins technology and artificial intelligence","author":"S Ortega-Martorell","year":"2024","journal-title":"Thromb Haemost"},{"issue":"10","key":"ref21","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1055\/a-2305-6631","article-title":"Association of cardiovascular health with the incidence of venous thromboembolism: a prospective study of 275,149 participants from the UK Biobank","volume":"124","author":"B Liang","year":"2024","journal-title":"Thromb Haemost"},{"issue":"05","key":"ref22","first-page":"e18","article-title":"Life's Essential 8: updating and enhancing the American Heart Association's construct of cardiovascular health: a presidential advisory from the American Heart Association","volume":"146","author":"D M Lloyd-Jones","year":"2022","journal-title":"Circulation"},{"issue":"10","key":"ref23","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1055\/s-0044-1788926","article-title":"Shifting priorities in the prevention of venous thromboembolism: time to focus on overall cardiovascular health","volume":"124","author":"S V Konstantinides","year":"2024","journal-title":"Thromb Haemost"},{"issue":"10","key":"ref24","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1055\/s-0044-1786970","article-title":"Obesity-related traits mediate the effects of educational attainment on the risk of varicose veins, venous thromboembolism, and phlebitis","volume":"124","author":"H-C Du","year":"2024","journal-title":"Thromb Haemost"},{"issue":"10","key":"ref25","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1055\/s-0044-1788904","article-title":"Educational attainment, obesity, and venous thromboembolism. Is only matter of weight?","volume":"124","author":"D Pastori","year":"2024","journal-title":"Thromb Haemost"},{"issue":"11","key":"ref26","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1055\/a-2313-0311","article-title":"Exploring the two-way link between migraines and venous thromboembolism: a bidirectional two-sample Mendelian randomization study","volume":"124","author":"Y Wang","year":"2024","journal-title":"Thromb Haemost"},{"issue":"07","key":"ref27","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1055\/s-0043-1778642","article-title":"Early time courses of recurrent venous thromboembolism and bleeding during apixaban or dalteparin therapy for patients with cancer","volume":"124","author":"A T Cohen","year":"2024","journal-title":"Thromb Haemost"},{"issue":"11","key":"ref28","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1055\/a-2316-5269","article-title":"Edoxaban, rivaroxaban, or apixaban for cancer-associated venous thromboembolism in the real world: insights from the COMMAND VTE Registry-2","volume":"124","author":"D Sueta","year":"2024","journal-title":"Thromb Haemost"},{"issue":"11","key":"ref29","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1055\/s-0044-1788997","article-title":"Open issues in the choice and management of direct oral anticoagulants in patients with cancer-related venous thromboembolism","volume":"124","author":"D Pastori","year":"2024","journal-title":"Thromb Haemost"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1055\/a-2259-0662","article-title":"Comparison of clinical outcomes in patients with active cancer receiving rivaroxaban or low-molecular-weight heparin: the OSCAR-UK study","author":"A T Cohen","year":"2024","journal-title":"Thromb Haemost"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1055\/a-2225-5428","article-title":"Risk of depression after venous thromboembolism in patients with hematological cancer: a population-based cohort study","author":"D Steiner","year":"2024","journal-title":"Thromb Haemost"},{"issue":"12","key":"ref32","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1055\/a-2107-0702","article-title":"Comprehensive analysis of hemophilia A (CAHEA): towards full characterization of the F8 gene variants by long-read sequencing","volume":"123","author":"Y Liu","year":"2023","journal-title":"Thromb Haemost"},{"issue":"01","key":"ref33","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1055\/s-0043-1777766","article-title":"Surgical experience from the STASEY study of emicizumab prophylaxis in people with hemophilia A with factor VIII inhibitors","volume":"8","author":"G Castaman","year":"2024","journal-title":"TH Open"},{"issue":"02","key":"ref34","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1055\/s-0044-1785525","article-title":"Management of urgent bleeding in patients with hemophilia A: focus on the use of emicizumab","volume":"8","author":"V Jim\u00e9nez-Yuste","year":"2024","journal-title":"TH Open"},{"issue":"02","key":"ref35","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1055\/s-0044-1785524","article-title":"Disease burden, clinical outcomes, and quality of life in people with hemophilia A without inhibitors in Europe: analyses from CHESS II\/CHESS PAEDs","volume":"8","author":"P Chowdary","year":"2024","journal-title":"TH Open"},{"issue":"01","key":"ref36","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1055\/s-0044-1781466","article-title":"Safety and efficacy of recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in previously untreated patients with hemophilia B","volume":"8","author":"R Lemons","year":"2024","journal-title":"TH Open"},{"issue":"01","key":"ref37","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1055\/a-2202-4296","article-title":"Anticoagulation-associated bleeding in patients screened for atrial fibrillation versus usual care\u2014a post hoc analysis from the LOOP study","volume":"8","author":"E K Kongebro","year":"2024","journal-title":"TH Open"},{"issue":"11","key":"ref38","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1055\/s-0044-1786028","article-title":"Clinical outcomes of patients with atrial fibrillation who survived from bleeding event: the results from COOL-AF Thailand registry","volume":"124","author":"A Winijkul","year":"2024","journal-title":"Thromb Haemost"},{"issue":"09","key":"ref39","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1055\/a-2278-8769","article-title":"Racial differences in ischemic and hemorrhagic stroke: an ecological epidemiological study","volume":"124","author":"D S Kang","year":"2024","journal-title":"Thromb Haemost"},{"issue":"09","key":"ref40","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1055\/a-2269-1123","article-title":"Racial differences in bleeding risk: an ecological epidemiological study comparing Korea and United Kingdom subjects","volume":"124","author":"D S Kang","year":"2024","journal-title":"Thromb Haemost"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-1770724","article-title":"Effect of oral anticoagulants in atrial fibrillation patients with polypharmacy: a meta-analysis","author":"Y Zheng","year":"2023","journal-title":"Thromb Haemost"},{"issue":"02","key":"ref42","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1055\/s-0043-1769735","article-title":"The impact of polypharmacy on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"124","author":"M Grymonprez","year":"2024","journal-title":"Thromb Haemost"},{"issue":"02","key":"ref43","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1055\/s-0043-1776900","article-title":"NOACs in atrial fibrillation patients with polypharmacy","volume":"124","author":"B Corica","year":"2024","journal-title":"Thromb Haemost"},{"issue":"08","key":"ref44","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1055\/a-2190-8705","article-title":"Platelet activation is upregulated in cirrhotic patients with portal vein thrombosis","volume":"124","author":"F Zhao","year":"2024","journal-title":"Thromb Haemost"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1055\/a-2373-3792","article-title":"Carbamylation is instrumental in end-stage kidney disease coagulopathies: the impact on von Willebrand factor and platelet functionality","author":"J Babickova","year":"2024","journal-title":"Thromb Haemost"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1055\/s-0044-1791550","article-title":"Carbamylation\u2014a pathologic posttranslational modification affecting platelet and von Willebrand factor function during uremic kidney disease","author":"R R Koenen","year":"2024","journal-title":"Thromb Haemost"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1055\/a-2398-9532","article-title":"Shear stress promotes remodeling of platelet glycosylation via upregulation of platelet glycosidase activity: one more thing","author":"Y Roka-Moiia","year":"2024"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1055\/a-2448-2989","article-title":"The hidden culprit: troubles with enhanced deglycosylation in mechanical circulatory support","author":"A Braun","year":"2024","journal-title":"Thromb Haemost"},{"issue":"06","key":"ref49","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1055\/a-2156-7872","article-title":"Effect of alirocumab added to high-intensity statin on platelet reactivity and noncoding RNAs in patients with AMI: a substudy of the PACMAN-AMI trial","volume":"124","author":"Y Ueki","year":"2024","journal-title":"Thromb Haemost"},{"issue":"06","key":"ref50","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1055\/s-0044-1782161","article-title":"The lipid-platelet interplay: unraveling the effects of PCSK9 inhibition on platelet reactivity","volume":"124","author":"L Ortega-Paz","year":"2024","journal-title":"Thromb Haemost"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1055\/s-0044-1789592","article-title":"Venous thromboembolism in patients with glioblastoma: molecular mechanisms and clinical implications","author":"M Y Kapteijn","year":"2024","journal-title":"Thromb Haemost"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1055\/a-2350-8338","article-title":"Heterozygous prothrombin mutation-associated thrombophilia","author":"X Wu","year":"2024","journal-title":"Thromb Haemost"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1055\/s-0044-1787957","article-title":"Novel insights into the aortic mechanical properties of mice modeling hereditary aortic diseases","author":"N Dubacher","year":"2024","journal-title":"Thromb Haemost"},{"issue":"08","key":"ref55","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1055\/a-2253-9359","article-title":"ADAMTS13 or caplacizumab reduces the accumulation of neutrophil extracellular traps and thrombus in whole blood of COVID-19 patients under flow","volume":"124","author":"N Yada","year":"2024","journal-title":"Thromb Haemost"},{"issue":"08","key":"ref56","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1055\/a-2263-8514","article-title":"Causal effects of COVID-19 on the risk of thrombosis: a two-sample Mendel randomization study","volume":"124","author":"Z Li","year":"2024","journal-title":"Thromb Haemost"},{"issue":"08","key":"ref57","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1055\/a-2315-8278","article-title":"Tissue factor pathway inhibitor and interleukin-1 receptor levels in COVID-19","volume":"124","author":"D A Gorog","year":"2024","journal-title":"Thromb Haemost"},{"issue":"12","key":"ref58","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1055\/a-2263-8372","article-title":"Inflammasome-independent mechanism of NLRP3 is critical for platelet GPIb-IX function and thrombosis","volume":"124","author":"X Chen","year":"2024","journal-title":"Thromb Haemost"},{"issue":"12","key":"ref59","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1055\/a-2413-4672","article-title":"NLRP3: more than an inflammasome?","volume":"124","author":"G J Pennings","year":"2024","journal-title":"Thromb Haemost"},{"issue":"06","key":"ref60","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1055\/a-2173-3602","article-title":"Macrophage ferroptosis promotes MMP2\/9 overexpression induced by hemin in hemorrhagic plaque","volume":"124","author":"B Li","year":"2024","journal-title":"Thromb Haemost"},{"issue":"09","key":"ref61","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1055\/a-1952-1159","article-title":"Carotid stenosis and stroke: medicines, stents, surgery\u2014\u201cwait-and-see\u201d or protect?","volume":"124","author":"P Musialek","year":"2024","journal-title":"Thromb Haemost"}],"container-title":["Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2495-1993.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T23:44:58Z","timestamp":1735947898000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2495-1993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":59,"journal-issue":{"issue":"01","published-online":{"date-parts":[[2025,1,3]]},"published-print":{"date-parts":[[2025,1]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2495-1993","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0340-6245","2567-689X"],"issn-type":[{"value":"0340-6245","type":"print"},{"value":"2567-689X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]}}}